Related Experiment Videos
Prostaglandin prophylaxis and bladder function after vaginal hysterectomy: a prospective randomised study
A Bergman1, Y Mushket, D Gordon
1University of Southern California School of Medicine, Women's Hospital, Los Angeles 90033.
British Journal of Obstetrics and Gynaecology
|January 1, 1993
Summary
Intravaginal prostaglandin E2 (PGE2) significantly improved bladder function after vaginal hysterectomy. This treatment accelerated spontaneous voiding and reduced catheterization duration and febrile morbidity.
Area of Science:
- Urogynecology
- Pharmacology
Background:
- Vaginal hysterectomy can lead to temporary bladder dysfunction.
- Postoperative urinary retention is a common complication.
Purpose of the Study:
- To evaluate the effectiveness of prostaglandins in improving bladder function post-vaginal hysterectomy.
Main Methods:
- A prospective randomized study involved 24 women undergoing vaginal hysterectomy.
- Participants received either intravaginal prostaglandin E2 (PGE2), intravesical prostaglandin F2 alpha (PGF2α), or saline (control).
Main Results:
- Intravaginal PGE2 accelerated the return of spontaneous bladder function.
- The PGE2 group required significantly less catheterization and experienced reduced febrile morbidity compared to controls and PGF2α group.
Conclusions:
- Intravaginal prostaglandin E2 is beneficial for enhancing bladder function after vaginal hysterectomy.
- PGE2 offers a promising therapeutic option for managing postoperative bladder dysfunction.